Shutaishen: application for clinical trial of STSA-1201 hypodermic injection accepted

FAP, May 9 (FAP)-recently, the State Drug Administration agreed to accept the application submitted by Shu Taishen for clinical trials of STSA-1201 hypodermic injection in the treatment of asthma.